Insider Transactions in Q2 2022 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2022
|
Brian Piekos CFO |
BUY
Grant, award, or other acquisition
|
Direct |
9,960
+36.12%
|
$9,960
$1.09 P/Share
|
|
Apr 13
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
191,769
+3.69%
|
$191,769
$1.52 P/Share
|
|
Apr 12
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
203,744
+4.07%
|
$203,744
$1.42 P/Share
|
|
Apr 12
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
55,000
+16.92%
|
$55,000
$1.36 P/Share
|
|
Apr 11
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
504,487
+9.87%
|
$504,487
$1.35 P/Share
|